Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Antifosfolipidsyndrom og graviditet

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Natarbejde og komplikationer i graviditeten

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Donorsøgning til Hæmatopoietisk stamcelle transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Somatiske årsager til akut opståede psykiatriske tilstande hos børn og unge

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Treatment of monogenic disorders with viral transduced haematopoietic stem cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early life body size, growth and risks of systemic lupus erythematosus - A large Danish observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pregnancy loss is associated with type 2 diabetes: a nationwide case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Wexner score and quality of life in women with obstetric anal sphincter injury

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Antiphospholipid syndrome (APS) is the association of antiphospholipid antibodies with thromboses and/or obstetric morbidity. Obstetric morbidity includes recurrent first trimester loss, stillbirth, intrauterine death, preeclam-psia, premature birth and fetal growth restriction. Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions. Women with APS are therefore high-risk pregnancies who should be monitored in specialist centres according to international standards.

Translated title of the contributionAntiphospholipid syndrome and pregnancy
Original languageDanish
JournalUgeskrift for Laeger
Volume178
Issue number3
Pages (from-to)2-5
ISSN0041-5782
Publication statusPublished - 18 Jan 2016

    Research areas

  • English Abstract, Journal Article

ID: 49824349